Circulating Prostate Cancer Progenitor Cell Assay Development

Award Information
Agency: Department of Defense
Branch: Army
Contract: W81XWH-08-C-0099
Agency Tracking Number: A2-4144
Amount: $747,553.00
Phase: Phase II
Program: STTR
Awards Year: 2011
Solicitation Year: 2008
Solicitation Topic Code: A08-T041
Solicitation Number: 2008.A
Small Business Information
73 High Street, Buffalo, NY, 14203-1149
DUNS: 193493157
HUBZone Owned: Y
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 Michael Zwick
 (716) 860-7920
Business Contact
 Michael Zwick
Title: CEO
Phone: (716) 860-7920
Research Institution
 Roswell Park Cancer Institute
 John T Blandino
 Elm and Carlton Streets
Buffalo, NY, 14263-
 (716) 845-2312
 Domestic nonprofit research organization
The technical objectives of this Phase II project are to identify unique biomarkers and produce molecular, antibody and peptide reagents that are specific for human prostate cancer progenitor stem cells. We propose to utilize the information from the Phase I award and subsequent research to develop assay reagents that would be used to develop a blood-based assay specific for circulating prostate cancer stem cells. This assay should prove to be an informative prognostic tool for predicting aggressiveness and metastatic potential of prostate cancer.

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government